Elaine Heron
Director/Board Member chez BIOMARIN PHARMACEUTICAL INC.
Fortune : 8 M $ au 30/04/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Paul Russo | M | 81 | 25 ans | |
Susan Dillon | M | - |
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA. | 6 ans |
Robert Emanuele | M | 69 |
Visgenx, Inc.
Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | - |
Mark Laurenzi | M | - |
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA. | - |
Jean-Jacques Bienaimé | M | 70 | 19 ans | |
Michael Finney | M | 65 | 17 ans | |
Todd Davis | M | 63 |
Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA. | 7 ans |
Wesley H. Kaupinen | M | - |
Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA. | 9 ans |
Elizabeth Anderson | F | 66 |
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA. | 6 ans |
Karyn O’Neil | M | - |
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA. | 6 ans |
Richard Nathan Ellson | M | - |
Labcyte, Inc.
Labcyte, Inc. Medical/Nursing ServicesHealth Services Labcyte, Inc. operates as a biotechnology tools company that manufactures and markets echo liquid handling systems. It offers liquid handling, automation and consumables. The company was founded by Richard Nathan Ellson and Mark D. Fischer-Colbrie and A. Mark Bramwell in October 2003 and is headquartered in Sunnyvale, CA. | 21 ans |
Santosh Vetticaden | M | 65 |
Visgenx, Inc.
Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | - |
Jeff Ajer | M | 61 | 19 ans | |
Sean Tucker | M | - | 20 ans | |
Randy Meier | M | 65 | 18 ans | |
Alexander Hardy | M | 56 | 1 ans | |
William Pedranti | M | - |
Visgenx, Inc.
Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | 1 ans |
Mark Enyedy | M | 60 | 1 ans | |
Dennis Joseph Slamon | M | 75 | 10 ans | |
Athena Countouriotis | M | 52 | 1 ans | |
Stuart Bunting | M | - | 16 ans | |
Robert Hombach | M | 58 | 7 ans | |
Philip Lo Scalzo | M | - | 17 ans | |
George Davis | M | 53 | 20 ans | |
Edward Berg | M | - | 6 ans | |
Brian Mueller | M | 50 | 22 ans | |
Barbara Bodem | F | 56 | 1 ans | |
Kelly Gardner | M | - |
Zephyrus Biosciences, Inc.
Zephyrus Biosciences, Inc. BiotechnologyHealth Technology Zephyrus Biosciences, Inc. provides tools for protein analysis at the single cell level. The firm's products include Z1 instrument, zWest Kits, and scWestern system which enables western blotting on individual cells. Its products are used to gain insights into the biology of cancer, stem cells, neurology, and human disease and development. The company was founded by Kelly Gardner, Amy E. Herr and Joshua Molho in 2013 and is headquartered in Berkeley, CA. | 11 ans |
Joshua Molho | M | - |
Zephyrus Biosciences, Inc.
Zephyrus Biosciences, Inc. BiotechnologyHealth Technology Zephyrus Biosciences, Inc. provides tools for protein analysis at the single cell level. The firm's products include Z1 instrument, zWest Kits, and scWestern system which enables western blotting on individual cells. Its products are used to gain insights into the biology of cancer, stem cells, neurology, and human disease and development. The company was founded by Kelly Gardner, Amy E. Herr and Joshua Molho in 2013 and is headquartered in Berkeley, CA. | 11 ans |
David Wheadon | M | 66 | 3 ans | |
Scott Greenberg | M | - |
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA. | 5 ans |
May Kin Ho | M | 71 | 3 ans | |
V. Lawlis | M | 72 | 17 ans | |
Bruce Peacock | M | 72 |
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA. | - |
Mark Alles | M | 64 | 2 ans | |
Simon P. Westbrook | M | 75 | 6 ans | |
Willard Dere | M | 70 | 8 ans | |
Chris Mirabelli | M | 69 |
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA. | 4 ans |
Robert Yedid | M | 66 | 5 ans | |
David Pyott | M | 70 | 8 ans | |
Emery Dora | M | - | 12 ans | |
Mike Baghramian | M | - | 3 ans | |
Amy Wireman | F | - | 11 ans | |
C. Guyer | M | 62 | 4 ans | |
Michael Christopher | M | - |
Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA. | - |
Sri Purisai | M | - | 5 ans | |
Deborah Baron | F | 55 |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | - |
Phillip Eric Lee | M | 37 | 2 ans | |
Marni Kottle | F | - | - | |
Daniel L. Chao | M | - |
Visgenx, Inc.
Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | - |
Erin Burkhart | F | 45 | 2 ans | |
Humaira Serajuddin | F | - | 2 ans | |
Dave Jacoby | M | - | 8 ans | |
Douglas Crawford | M | - |
Zephyrus Biosciences, Inc.
Zephyrus Biosciences, Inc. BiotechnologyHealth Technology Zephyrus Biosciences, Inc. provides tools for protein analysis at the single cell level. The firm's products include Z1 instrument, zWest Kits, and scWestern system which enables western blotting on individual cells. Its products are used to gain insights into the biology of cancer, stem cells, neurology, and human disease and development. The company was founded by Kelly Gardner, Amy E. Herr and Joshua Molho in 2013 and is headquartered in Berkeley, CA. | - |
Kevin Eggan | M | - | 4 ans | |
Anand Mehra | M | 48 |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | - |
Timothy J. Henkel | M | 65 |
Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA. | - |
Peter Staple | M | 72 | 3 ans | |
Jon Saxe | M | 88 | 3 ans | |
Hus Tigli | M | - | - | |
Arthur Becker | M | 74 |
Visgenx, Inc.
Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | - |
George M. Jenkins | M | - |
Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA. | - |
Thomas Meier | M | 62 |
Visgenx, Inc.
Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | 2 ans |
Chris LeMasters | M | - |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | 4 ans |
James Cummings | M | - | 3 ans | |
Garnet Peck | M | 93 |
Purdue University
| 57 ans |
Raidy Kevin J. | M | 55 |
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA. | - |
John Doux | M | - |
Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA. | - |
Niall O'Donnell | M | 51 |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | - |
Traci McCarty | F | - | - | |
William Mark Watson | M | 73 | 2 ans | |
Amy E. Herr | M | - |
Zephyrus Biosciences, Inc.
Zephyrus Biosciences, Inc. BiotechnologyHealth Technology Zephyrus Biosciences, Inc. provides tools for protein analysis at the single cell level. The firm's products include Z1 instrument, zWest Kits, and scWestern system which enables western blotting on individual cells. Its products are used to gain insights into the biology of cancer, stem cells, neurology, and human disease and development. The company was founded by Kelly Gardner, Amy E. Herr and Joshua Molho in 2013 and is headquartered in Berkeley, CA. | 11 ans |
Raymond Stapleton | M | - | 2 ans | |
Deepak Kamlani | M | - | 4 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Andrei Floroiu | M | 51 | 4 ans | |
Ciara Kennedy | M | 52 |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | - |
Michael Grey | M | 71 |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | 16 ans |
Mark D. Fischer-Colbrie | M | 67 |
Labcyte, Inc.
Labcyte, Inc. Medical/Nursing ServicesHealth Services Labcyte, Inc. operates as a biotechnology tools company that manufactures and markets echo liquid handling systems. It offers liquid handling, automation and consumables. The company was founded by Richard Nathan Ellson and Mark D. Fischer-Colbrie and A. Mark Bramwell in October 2003 and is headquartered in Sunnyvale, CA. | 16 ans |
Adora Ndu | M | 43 | 5 ans | |
Frederick Dale Fischer | M | 73 |
Purdue University
| 5 ans |
Marwan Al-Mouasher | M | 67 |
Purdue University
| 8 ans |
Mitchell Mutz | M | 61 |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | 10 ans |
James A. Tompkins | M | - |
Purdue University
| 7 ans |
Pierre LaPalme | M | 83 | 12 ans | |
Robert S. Weiner | M | - |
Purdue University
| 4 ans |
Sandra Shpilberg | F | 48 | 9 ans | |
Paul W. Hemmer | M | - |
Purdue University
| 5 ans |
Harold C. Smith | M | - |
Purdue University
| 7 ans |
W. Dwight Armstrong | M | - |
Purdue University
| 3 ans |
Adel A. Zakaria | M | - |
Purdue University
| 4 ans |
Stephen Brand | M | 74 |
Purdue University
| 4 ans |
Joshua Grass | M | - | 14 ans | |
Julie Cherrington | M | 66 | 1 ans | |
Ronald Parratt | M | 75 |
Purdue University
| 6 ans |
Wayne Clinton Ramsey | M | - |
Purdue University
| 5 ans |
Joseph C. Tucker | M | 76 |
Purdue University
| 4 ans |
Dan Spiegelman | M | 65 | 8 ans | |
Kim Tsuchimoto | F | 61 | 8 ans | |
Louis C. Drapeau | M | 79 | 3 ans | |
Jill Howe | F | 48 |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | 1 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 100 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Elaine Heron
- Réseau Personnel